Frequent activation of the noncanonical NF-κB pathway has also been reported in all DLBCL subtypes [19] regardless of the canonical pathway status, indicating that noncanonical NF-κB signaling also represents a major driver of DLBCL. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.